Crotalus atrox snake venom metalloproteinase (SVMP)

Crotalus atrox snake venom metalloproteinases (SVMPs) are a group of zinc-dependent enzymes that serve as primary toxins in the venom of the Western Diamondback Rattlesnake [UniProt: P0C2P0]. These enzymes belong to the M12B family of reprolysins and are categorized into PI, PII, and PIII classes based on their domain architecture, which includes a catalytic metalloproteinase domain and often disintegrin-like or cysteine-rich domains [PubMed: 16019215]. Their primary biological function involves the degradation of extracellular matrix components, such as type IV collagen and laminin, which are essential for the structural integrity of capillary basement membranes [PubMed: 21111745]. This proteolytic action leads to microvascular rupture, resulting in the characteristic local and systemic hemorrhage, edema, and tissue necrosis associated with Crotalus atrox envenomation [StatPearls: Snake Toxicity, 2023]. SVMPs also interfere with the coagulation cascade by degrading fibrinogen and inhibiting platelet function, contributing to systemic coagulopathy [PubMed: 11386661]. Clinically, these enzymes are the therapeutic targets of polyvalent antivenoms like CroFab and Anavip, which utilize purified antibody fragments to bind and neutralize the toxins [FDA: CroFab Label, 2021]. Additionally, research into small-molecule inhibitors, such as metal chelators and peptidomimetic metalloproteinase inhibitors, aims to provide adjunct treatments that can be administered more rapidly to prevent permanent tissue damage [PubMed: 30145214].

Other names

Western diamondback rattlesnake venom metalloproteinaseAtroxlysinHemorrhagic toxinReprolysin-like metalloproteinase

Neutralization of enzymatic activity via antibody-mediated sequestration or competitive inhibition of the zinc-dependent catalytic site.